Injective vs NAVI Protocol — how do they compare? Injective trades at Rp92,485 (market cap Rp9,26T, Rp1,73T 24h volume), while NAVI Protocol trades at Rp130.58 (market cap Rp106,88M, Rp5,09M 24h volume). The key difference: Injective is far larger — about 86639.2× NAVI Protocol's market cap, and NAVI Protocol's supply is capped (816,2M / 1B NAVX (82%)) while Injective's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and NAVI Protocol for 12 Days on average.
| INJ | NAVX | |
|---|---|---|
Market Cap | Rp9,26T | Rp106,88M |
Volume (24h) | Rp1,73T | Rp5,09M |
Circulating Supply | 100M INJ | 816,2M / 1B NAVX (82%) |
Typical Hold Time | 36 Days | 12 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
NAVI Protocol (NAVX) is trading at Rp130.83 with a market cap of Rp106.8M, showing bullish technical signals despite bearish moving averages. The token is approaching resistance at Rp131 with strong support at Rp127. With 82% of max supply in circulation and average hold time of 12 days, the asset demonstrates moderate network participation. No major protocol updates were identified in recent analysis.
Overall outlook remains cautiously optimistic with technical indicators favoring bullish momentum, though proximity to resistance levels suggests potential near-term consolidation. Key opportunities include positive oscillator signals and strong ADX readings, while risks involve limited liquidity depth and the token's small market cap vulnerability to volatility.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →NAVI Protocol is a decentralized oracle and lending protocol on the Sui blockchain. It enables users to lend and borrow cryptocurrency without intermediaries, creating an autonomous financial ecosystem. The protocol features a modular DeFi infrastructure with various contract modules, including incentivev2, calculator, dynamiccalculator, and storage. These modules improve functionality for a better user experience. For the contract address and technical details, visit the NAVI Protocol Developer Docs.
Read more on NAVX →